Bansi Pujara

Bansi Pujara

Active Director Director DIN 08776587
DIN 08776587 First appointment Jun 2020 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jun 2020
Shareholding value Locked Premium profile

About Bansi Pujara

Bansi Pujara has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Ulterius Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08776587
Primary Designation Director
First Appointment 30 Jun 2020
Oldest Company Age 6 yrs

Current companies

Company Designation Appointment Founded Status
Director 30 Jun 2020 2020 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ulterius Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bansi Pujara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bansi Pujara

Bansi Pujara has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Ulterius Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Bansi Pujara is associated with 1 company as Director.

Bansi Pujara has expertise in General Business.

Bansi Pujara has 6 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available